GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.
The FDA approves two new drugs for gonorrhoea treatment, with Dr. Reddy’s to market one in Thailand and South Africa.
GlobalData forecasts the hepatitis B therapeutics market will more than double to $3.2B by 2034, driven by functional cure ...
London: GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
The US Food and Drug Administration (FDA) on Friday announced it has approved two new oral medicines to treat a common ...
London: GSK has announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application for ...
EMA committee recommends approval of GSK’s RSV vaccine, Arexvy for all adults 18 years and older: London, UK Saturday, December 13, 2025, 13:00 Hrs [IST] GSK plc announced that ...
RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...
We’re working to professionalise medical aesthetics industry in NigeriaBy Christy AnyanwuBimbola Ige, CEO of Celeb Laser and Aesthetics Clinic, shares her journey into the world of medical aesthetics, ...